These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4979708)

  • 21. [Resensitization of resistant mycobacterial strains to antitubercular drugs].
    Vercellino E
    G Mal Infett Parassit; 1968 Feb; 20(2):191-3. PubMed ID: 4984621
    [No Abstract]   [Full Text] [Related]  

  • 22. Point mutations within the fatty acid synthase type II dehydratase components HadA or HadC contribute to isoxyl resistance in Mycobacterium tuberculosis.
    Gannoun-Zaki L; Alibaud L; Kremer L
    Antimicrob Agents Chemother; 2013 Jan; 57(1):629-32. PubMed ID: 23114755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary resistance of Mycobacterium tuberculosis in the province of Vizcaya].
    Echeverría MJ; Ayarza R; Jiménez MS; López de Goicoechea MJ; Berdonces P; Ibarretxebea AB
    Rev Esp Quimioter; 1999 Jun; 12(2):152-3. PubMed ID: 10562678
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antitubercular effect of capreomycin in vitro].
    Janowiec M
    Gruzlica; 1969 Jul; 37(7):629-35. PubMed ID: 4981783
    [No Abstract]   [Full Text] [Related]  

  • 25. [Resistance to antitubercular drugs in Chile].
    Valenzuela MT; Scheel G; Ponce J; Lepe R; Velasco M; Valenzuela P
    Rev Med Chil; 1984 Jan; 112(1):76-80. PubMed ID: 6429808
    [No Abstract]   [Full Text] [Related]  

  • 26. Trends in drug resistance of mycobacterium tuberculosis.
    Hejny J
    Indian J Chest Dis Allied Sci; 1982; 24(2-3):190-4. PubMed ID: 6819998
    [No Abstract]   [Full Text] [Related]  

  • 27. Mycobacterium tuberculosis drug resistance: a call to action.
    Sudre P; Cohn DL
    Int J Tuberc Lung Dis; 1998 Aug; 2(8):609-11. PubMed ID: 9712272
    [No Abstract]   [Full Text] [Related]  

  • 28. [Isoxyl and T283 in the treatment of photochromogenic infections in mice].
    Burjanová B; Dornetzhuber V
    Z Tuberk Erkr Thoraxorg; 1967; 127(1):123-5. PubMed ID: 5632189
    [No Abstract]   [Full Text] [Related]  

  • 29. [Some problems of the evaluation of new, tuberculostatic-acting substances in the test tube].
    Trnka L; Urbancík R; Havel A
    Wien Med Wochenschr; 1967 Feb; 117(6):146-51. PubMed ID: 4969980
    [No Abstract]   [Full Text] [Related]  

  • 30. [Critical remarks on a clinical test of an antitubercular agent. Experiences with thiocarlide during collective work].
    Mlczoch F; Wildner F
    Prax Pneumol; 1969 Jan; 23(1):1-16. PubMed ID: 4978559
    [No Abstract]   [Full Text] [Related]  

  • 31. [Should isoxyl in its current dosage continue to be used as an antitubercular agent?].
    Steffen J
    Prax Pneumol; 1971 May; 25(5):263-77. PubMed ID: 4997343
    [No Abstract]   [Full Text] [Related]  

  • 32. [Activity of Isoxyl on Mycobacterium kansasii; studies in vitro and in the pneumoconiotic guinea pig].
    Tacquet A; Devulder B; Tison F; Martin JC
    Antibiot Chemother; 1970; 16():160-76. PubMed ID: 5535612
    [No Abstract]   [Full Text] [Related]  

  • 33. [Heterogeneity of drug-resistant strains of Mycobacterium tuberculosis].
    Belogurova VP
    Probl Tuberk; 1970; 48(9):76-9. PubMed ID: 4996497
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug dependance of Mycobacterium tuberculosis].
    Mel'nikov EL
    Probl Tuberk; 1969; 47(5):60-4. PubMed ID: 4983819
    [No Abstract]   [Full Text] [Related]  

  • 35. [Dynamics of drug resistance and restoration of sensitivity of Mycobacterium tuberculosis isolated from patients].
    Belogurova VP; Navrotskiĭ VV
    Antibiotiki; 1970 May; 15(5):434-7. PubMed ID: 4988018
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug resistance in M. tuberculosis cultures determined by the Steenken MIC and Canetti proportion tests.
    Montalbine V; Collins FM; Doster B
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jan; 3(1):78-80. PubMed ID: 4985844
    [No Abstract]   [Full Text] [Related]  

  • 37. Detection of resistance to isoniazid in clinical isolates of Mycobacterium tuberculosis by molecular techniques.
    Sharma M; Altamirano M; Prasad HK; Myneedo VP; Nand N
    J Assoc Physicians India; 2001 Jul; 49():772-3. PubMed ID: 11573575
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experimental antitubercular activity of rifampicin, a derivative of rifamycin SV].
    Grumbach F; Rist N
    Rev Tuberc Pneumol (Paris); 1967; 31(6):749-62. PubMed ID: 4988378
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study of primary resistance to antitubercular agents in the Sousse region, 1981-1990].
    Benzarti M; Garrouche A; Jerray M; Hayouni A; Maalel K; Klabi N
    Tunis Med; 1996 Jan; 74(1):23-7. PubMed ID: 9507309
    [No Abstract]   [Full Text] [Related]  

  • 40. [Restoration of drug sensitivity in Mycobacterium tuberculosis to streptomycin and isoniazid during treatment with preparations of the 1st series].
    Rudoĭ NM; Utkin VV; Fedorova IE; Afanas'eva IuP
    Antibiotiki; 1970 Apr; 15(4):355-7. PubMed ID: 4993044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.